Navigation Links
Lexicon to Report Fourth Quarter and Year End 2011 Financial Results on February 22, 2012
Date:2/16/2012

rating results, discovery and development of products, strategic alliances and intellectual property, as well as other matters that are not historical facts or information.  All forward-looking statements are based on management's current assumptions and expectations and involve risks, uncertainties and other important factors, specifically including those relating to Lexicon's ability to successfully conduct preclinical and clinical development of its potential drug candidates, advance additional candidates into preclinical and clinical development, obtain necessary regulatory approvals, achieve its operational objectives, obtain patent protection for its discoveries and establish strategic alliances, as well as additional factors relating to manufacturing, intellectual property rights, and the therapeutic or commercial value of its drug candidates, that may cause Lexicon's actual results to be materially different from any future results expressed or implied by such forward-looking statements.  Information identifying such important factors is contained under "Risk Factors" in Lexicon's annual report on Form 10-K for the year ended December 31, 2010, as filed with the Securities and Exchange Commission.  Lexicon undertakes no obligation to update or revise any such forward-looking statements, whether as a result of new information, future events or otherwise.

 


'/>"/>
SOURCE Lexicon Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
2. Lexicon Reports Initial Clinical Trial Results for LX1031, an Investigational New Drug for Irritable Bowel Syndrome
3. Lexicon Files Investigational New Drug Application for LX2931 as a Potential Treatment for Rheumatoid Arthritis
4. Lexicon Initiates Phase 2a Trial of LX6171 Drug Candidate for Cognitive Disorders
5. Lexicon Presents Clinical Data on LX1032 for Carcinoid Syndrome at European Neuroendocrine Tumor Society Meeting
6. Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 First Quarter Results
7. Lexicons Drug Candidate LX1032 for Carcinoid Syndrome Receives Orphan Drug Designation From EMEA
8. Lexicon Completes Phase 1 Clinical Trial and Initiates Phase 2 Clinical Trial of LX4211 in Patients With Type 2 Diabetes
9. Lexicon Announces Pricing of Common Stock in Public Offering
10. Lexicon Announces Completion of Public Offering of Common Stock
11. Lexicon Pharmaceuticals to Present at the 12th Annual BIO CEO & Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... Aug. 28, 2014 Pharmatech initiated enrollment ... into this game-changing method for matching cancer patients ... clinical trials target specific cancers, disease staging, and ... for the cancer, in the first place. The ... information may not be well known to the ...
(Date:8/28/2014)... -- In anticipation of the upcoming MEDevice San Diego ... first time. Industry Overview: Medtech & Life Sciences in ... of San Diego,s critical involvement in ... employment statistics to current venture capital investment trends, the infographic ... such a vital part of the global medical device industry. ...
(Date:8/28/2014)... 2014 Nonin Medical, Inc., the inventor of ... monitoring, today announced that the Food and Drug Administration ... pulse oximeter for use in the United ... a telemedicine hub or kiosk through a USB connector ... to adult patients. The Model 3231 received EU certification ...
Breaking Medicine Technology:Enrollment in Pharmatech's Revolutionary AccessPPM Program Launches 2New Infographic Published - Overview of Medtech & Life Sciences Industry in San Diego 2Nonin Medical Announces FDA Clearance of Nonin Model 3231 USB Pulse Oximeter 2
... PRO-DEX, INC. (Nasdaq: PDEX ) invites investors and ... fiscal 2012 first quarter financial results. (Logo:   ... be broadcast live over the internet on Wednesday, November 9, ... and may be accessed by visiting the Company,s website at ...
... VIEW, Calif., Nov. 3, 2011 VIVUS, Inc. (NASDAQ: ... were published in Obesity, the peer-reviewed journal of The ... the investigational drug Qnexa in 1,267 severely obese (BMI >/= 35 ... addition to average weight loss of 14.4% of initial body weight ...
Cached Medicine Technology:Pro-Dex, Inc. Announces Fiscal 2012 First Quarter Financial Results Conference Call and Webcast 2Qnexa® Phase 3 Data Published In Obesity Show 14.4% Average Weight Loss In Severely Obese Patients Completing One Year Of Treatment 2Qnexa® Phase 3 Data Published In Obesity Show 14.4% Average Weight Loss In Severely Obese Patients Completing One Year Of Treatment 3Qnexa® Phase 3 Data Published In Obesity Show 14.4% Average Weight Loss In Severely Obese Patients Completing One Year Of Treatment 4Qnexa® Phase 3 Data Published In Obesity Show 14.4% Average Weight Loss In Severely Obese Patients Completing One Year Of Treatment 5Qnexa® Phase 3 Data Published In Obesity Show 14.4% Average Weight Loss In Severely Obese Patients Completing One Year Of Treatment 6
(Date:8/28/2014)... Dallas, TX (PRWEB) August 29, 2014 ... and in-depth study on the current state of the ... provides a basic overview of the industry, including definitions, ... Chinese domestic market analysis are provided with a focus ... market. A comparison between the international and Chinese situation ...
(Date:8/28/2014)... about the chance of ,overdiagnosis, through the NHS breast ... according to research published in the British Journal ... survey of around 2,200 women, Cancer Research UK scientists ... cent felt they fully understood the information given about ... cancers that would never have gone on to cause ...
(Date:8/28/2014)... Arizona State University graduate student Anthony Gonzales, ... named one of five finalists in Entrepreneur magazine’s 2014 ... the fourth consecutive year that an ASU student has ... of SafeSIPP, and JJ Tang, co-founder of Vantage Realized, ... ASU dominated the competition: Three of the five finalists ...
(Date:8/28/2014)... the federal government plans its exit strategy from the war, ... role in providing health care to veterans, says a Perspective ... , "To simply go on doing more of the same ... Health Administration,s cost and population structure pose in the longer ... Policy & Clinical Practice, and David Auerbach, from the RAND ...
(Date:8/28/2014)... Pittsburgh, PA (PRWEB) August 28, 2014 ... Ready Nutrition announced today a regional partnership designed ... and goal planning for competitive young athletes, scholastic ... , “Our partnership’s Strong Body & Mind Initiative ... that addresses both the physical and mental dynamics ...
Breaking Medicine News(10 mins):Health News:Global Oscilloscope Industry (North America, Europe, Asia, and ROW) Forecast Report 2020 Now Available at ReportsnReports.com 2Health News:Global Oscilloscope Industry (North America, Europe, Asia, and ROW) Forecast Report 2020 Now Available at ReportsnReports.com 3Health News:Some women still don't underststand 'overdiagnosis' risk in breast screening 2Health News:Arizona State University Grad Student in the Running for College Entrepreneur of the Year 2Health News:Arizona State University Grad Student in the Running for College Entrepreneur of the Year 3Health News:A VA exit strategy 2Health News:Allegheny Health Network and Come Ready Nutrition Announce Regional Partnership 2Health News:Allegheny Health Network and Come Ready Nutrition Announce Regional Partnership 3Health News:Allegheny Health Network and Come Ready Nutrition Announce Regional Partnership 4
... patients is often discouraged because of fears of complications. ... has shown that minimally invasive, or arthroscopic, surgery can significantly ... published online in Arthroscopy: The Journal of Arthroscopic ... issue. "In people over the age of 70, pain ...
... TUESDAY, Aug. 31 (HealthDay News) -- Women who carry genetic ... can live longer and reduce their cancer risk by having ... question is drastic: removal of the breasts or ovaries before ... findings show is that women who choose to have these ...
... most difficult aspects of working at the nanoscale is actually ... which are smaller than the wavelength of light, are invisible ... native form with other imaging techniques. A ... not only visualize a virus but to use the results ...
... researchers have calculated the probability of dying in road accidents ... services to arrive. Their conclusions are clear reducing the ... the emergency services from 25 to 15 minutes would cut ... after an accident until the emergency medical services arrive is ...
... exposed to violence in their community are at an increased ... asthma or any cause, according to new research from the ... violence has been linked to more symptoms in pediatric asthma ... a longitudinal study showing a connection in an adult population ...
... Institute announced today new study results showing an early marker ... higher-risk for autism may be infrequent gazing at other people ... Journal of Child Psychology and Psychiatry , the study also ... cause and effect learning skills when compared to low-risk infants ...
Cached Medicine News:Health News:Surgery to repair torn shoulder muscles in the elderly can reduce pain and improve function 2Health News:Preventive Surgeries May Be Lifesaver for Women at High Cancer Risk 2Health News:Preventive Surgeries May Be Lifesaver for Women at High Cancer Risk 3Health News:Novel nanotechnology collaboration leads to breakthrough in cancer research 2Health News:Novel nanotechnology collaboration leads to breakthrough in cancer research 3Health News:10 minutes could prevent one-third of road deaths 2Health News:Violence in inner city neighborhoods contributes to trouble with asthma 2Health News:Infant's gaze may be an early, but subtle, marker for autism risk 2Health News:Infant's gaze may be an early, but subtle, marker for autism risk 3
...
... monitor is designed to automatically measure and ... along with heart rate. It's a Blood ... treadmill, ergometer and pharmacological stress test environments. ... research environments., ,Tango excels where other ...
...
...
Medicine Products: